Skip to main content
NAGE logo
NAGE
(NASDAQ)
Niagen Bioscience, Inc.
$4.38-- (--)
Loading... - Market loading

Niagen Bioscience (NAGE) Stock Price & Financial Analysis

Niagen Bioscience Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.32 - $4.45
52-Week High$14.69
52-Week Low$4.16
Open$4.43
Volume750.88K
Average Volume (3M)750.88K
Market Cap374.21M
Shares Outstanding85.44M
P/E Ratio (TTM)22.22
Forward P/E10.98
Price to Sales (P/S)2.98
Price to Book (P/B)5.05
EV/EBITDA19.96
Revenue (TTM)129.42M
Net Income (TTM)17.38M
Free Cash Flow (TTM)13.16M
EPS (TTM)$0.21
Profit Margin13.43%
Operating Margin11.05%
Return on Equity (ROE)22.71%
Debt to Equity0.04
50-Day MA$5.14
200-Day MA$7.82
52-Week Change-34.21%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Niagen Bioscience

What is the current stock price for NAGE?

As of the latest trading session, NAGE stock trades at $4.38. The 52-week range is $4.16–$14.69, with a day range of $4.32–$4.45.

What is the P/E ratio for NAGE?

Niagen Bioscience's trailing P/E ratio is 22.2, meaning investors pay $22.2 for every $1 of annual earnings. The forward P/E is 11.0, reflecting analyst expectations for future earnings. Niagen Bioscience operates in the Healthcare sector.

Does NAGE pay dividends?

Niagen Bioscience does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NAGE?

Based on 1 analyst, the consensus for NAGE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NAGE?

Niagen Bioscience's market capitalization is $374.2M, classifying it as a small-cap company. Niagen Bioscience operates in the Healthcare sector within the Biotechnology industry.